(Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups
A Prospective, Cross-Sectional, Case-Control, Molecular Study of Health Assessment and Risk in Ethnic Groups
Sponsor: Hamilton Health Sciences Corporation
Listed as NCT00249314, this observational or N/A phase trial focuses on Cardiovascular Diseases and Insulin Resistance and remains ongoing. Sponsored by Hamilton Health Sciences Corporation, it has been updated 6 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Nov 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hamilton Health Sciences Corporation
- Heart and Stroke Foundation of Canada
For direct contact, visit the study record on ClinicalTrials.gov .